Xuefeng Ma

715 total citations
21 papers, 490 citations indexed

About

Xuefeng Ma is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, Xuefeng Ma has authored 21 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 10 papers in Molecular Biology and 7 papers in Hepatology. Recurrent topics in Xuefeng Ma's work include Liver Disease Diagnosis and Treatment (10 papers), MicroRNA in disease regulation (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Xuefeng Ma is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), MicroRNA in disease regulation (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Xuefeng Ma collaborates with scholars based in China and Netherlands. Xuefeng Ma's co-authors include Yongning Xin, Jie Zhang, Shousheng Liu, Mengzhen Dong, Yifen Wang, Mengke Wang, Likun Zhuang, Lizhen Chen, Jie Zhang and Xin Luo and has published in prestigious journals such as Science Advances, Archives of Biochemistry and Biophysics and Frontiers in Pharmacology.

In The Last Decade

Xuefeng Ma

19 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuefeng Ma China 13 213 152 99 76 65 21 490
Jingwei Mao China 14 129 0.6× 237 1.6× 57 0.6× 27 0.4× 30 0.5× 33 632
J Petrtýl Czechia 15 157 0.7× 98 0.6× 38 0.4× 161 2.1× 24 0.4× 51 639
M Hussain United Kingdom 5 200 0.9× 169 1.1× 31 0.3× 79 1.0× 39 0.6× 14 437
Salih Boğa Türkiye 12 141 0.7× 70 0.5× 21 0.2× 52 0.7× 38 0.6× 27 478
Saman Nikeghbalian Iran 12 73 0.3× 85 0.6× 28 0.3× 60 0.8× 53 0.8× 57 415
George Khoudari United States 10 165 0.8× 139 0.9× 98 1.0× 55 0.7× 23 0.4× 34 581
Tsung‐Ming Yang Taiwan 14 59 0.3× 194 1.3× 48 0.5× 23 0.3× 14 0.2× 38 578
Guoqing Ouyang China 13 150 0.7× 122 0.8× 93 0.9× 82 1.1× 21 0.3× 25 630
Hideko Ohama Japan 13 267 1.3× 121 0.8× 47 0.5× 258 3.4× 54 0.8× 53 659

Countries citing papers authored by Xuefeng Ma

Since Specialization
Citations

This map shows the geographic impact of Xuefeng Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefeng Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefeng Ma more than expected).

Fields of papers citing papers by Xuefeng Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuefeng Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefeng Ma. The network helps show where Xuefeng Ma may publish in the future.

Co-authorship network of co-authors of Xuefeng Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Xuefeng Ma. A scholar is included among the top collaborators of Xuefeng Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuefeng Ma. Xuefeng Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Jie, et al.. (2024). RNA-binding protein QKI promotes the progression of HCC by interacting with long non-coding RNA EGOT. International Immunopharmacology. 136. 112297–112297. 4 indexed citations
5.
Ma, Xuefeng, Zheng Xu, Shousheng Liu, et al.. (2022). Relationship of circulating total bilirubin, UDP-glucuronosyltransferases 1A1 and the development of non-alcoholic fatty liver disease: a cross-sectional study. BMC Gastroenterology. 22(1). 6–6. 3 indexed citations
6.
Tan, Jie, Jie Zhang, Mengke Wang, et al.. (2021). DRAM1 increases the secretion of PKM2-enriched EVs from hepatocytes to promote macrophage activation and disease progression in ALD. Molecular Therapy — Nucleic Acids. 27. 375–389. 18 indexed citations
7.
Ma, Xuefeng, et al.. (2021). The Wnt pathway regulator expression levels and their relationship to bone metabolism in thoracolumbar osteoporotic vertebral compression fracture patients.. American Journal of Translational Research. 13(5). 4812–4818. 12 indexed citations
8.
Liang, Yan, Yi Liu, Xuefeng Ma, et al.. (2021). Triclabendazole Induces Pyroptosis by Activating Caspase-3 to Cleave GSDME in Breast Cancer Cells. Frontiers in Pharmacology. 12. 670081–670081. 37 indexed citations
9.
Ma, Xuefeng, et al.. (2021). Surfactant-assisted carbon black for the electrochemical detection of endocrine disruptors. Surfaces and Interfaces. 24. 101128–101128. 21 indexed citations
10.
Xin, Yongning, Jie Tan, Jian Zhang, et al.. (2020). The association between SNPs rs1800591 and rs3816873 of the MTTP gene and nonalcoholic fatty liver disease: A meta-analysis. Saudi Journal of Gastroenterology. 26(4). 171–171. 6 indexed citations
11.
Ma, Xuefeng, Shousheng Liu, Lizhen Chen, et al.. (2020). The clinical characteristics of pediatric inpatients with SARS‐CoV‐2 infection: A meta‐analysis and systematic review. Journal of Medical Virology. 93(1). 234–240. 52 indexed citations
12.
Liu, Shousheng, Xuefeng Ma, Jie Zhao, et al.. (2020). Association between nonalcoholic fatty liver disease and extrahepatic cancers: a systematic review and meta-analysis. Lipids in Health and Disease. 19(1). 118–118. 54 indexed citations
13.
Zhang, Qing, Xuefeng Ma, Mengzhen Dong, et al.. (2020). MiR-30b-5p regulates the lipid metabolism by targeting PPARGC1A in Huh-7 cell line. Lipids in Health and Disease. 19(1). 76–76. 32 indexed citations
14.
Ma, Xuefeng, Shousheng Liu, Jie Zhang, et al.. (2020). Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis. BMC Gastroenterology. 20(1). 10–10. 105 indexed citations
15.
Zhang, Qing, et al.. (2020). Roles and regulatory mechanisms of miR‑30b in cancer, cardiovascular disease, and metabolic disorders (Review). Experimental and Therapeutic Medicine. 21(1). 44–44. 18 indexed citations
16.
Ma, Xuefeng, Shousheng Liu, Jie Zhang, et al.. (2020). Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis. Research Square. 3 indexed citations
18.
Liu, Shousheng, Xuefeng Ma, Jie Zhao, et al.. (2020). Association between nonalcoholic fatty liver disease and extrahepatic cancers: a systematic review and meta-analysis. Research Square. 1 indexed citations
19.
Ma, Xuefeng, et al.. (2015). IKKβ/NF-κB mediated the low doses of bisphenol A induced migration of cervical cancer cells. Archives of Biochemistry and Biophysics. 573. 52–58. 57 indexed citations
20.
Wang, Binbin, Meng Du, Jing Wang, et al.. (2011). Genetic association of polymorphism rs1333049 with gout. Lara D. Veeken. 50(9). 1559–1561. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026